Analysis of seven common side effects of Sunitinib (Sutent) and countermeasures

Sunitinib (Sunitinib) is an oral multi-target tyrosine kinase inhibitor, mainly used to treat renal clear cell carcinoma, gastrointestinal stromal tumor (GIST) and certain pancreatic neuroendocrine tumors. Although sunitinib has outstanding clinical efficacy, because it acts on multiple signaling pathways, patients may experience a variety of side effects during the medication. Understanding these common side effects and effective countermeasures can help improve patients' medication compliance and quality of life. Here are seven common side effects and strategies to deal with them.

1. Fatigue and weakness

Fatigue is one of the most common side effects of sunitinib. Patients may experience general weakness, decreased concentration, or even difficulty in daily life. Response measures include rationally arranging work and rest time to avoid overexertion; moderate exercise, such as walking or mild stretching, can improve physical strength and mental state; ensuring a balanced diet and adequate protein and vitamin intake; if fatigue is severe, consult a doctor to evaluate whether drug dosage needs to be adjusted.

2. Digestive system reaction

Gastrointestinal adverse reactions such as nausea, vomiting, diarrhea, and loss of appetite are relatively common. Such side effects can be alleviated by eating small amounts in portions and avoiding greasy and irritating foods; under the guidance of a doctor, antiemetics or antidiarrheal drugs can be used; maintaining water and electrolyte balance to prevent dehydration. For patients with long-term diarrhea or loss of appetite leading to weight loss, timely medical treatment is required to prevent malnutrition.

3. Hypertension

Sunitinib can cause an increase in blood pressure, and some patients may experience headache, dizziness, or heart palpitations. Response measures include regular monitoring of blood pressure, and families can bring their own electronic sphygmomanometers; according to the doctor's advice, combined with antihypertensive drug treatment when necessary; pay attention to a low-salt diet and limit foods with high sodium content; if persistent high blood pressure or obvious symptoms occur, contact the doctor in time to evaluate whether to adjust the medication dosage or discontinue the medication.

4. Hand-foot syndrome

Hand-foot syndrome presents with erythema, pain, blisters, or scaling on the palms or soles of the feet. Preventive measures include keeping the skin of hands and feet clean and dry, using mild hand cream; avoiding prolonged friction or contact with hot water; wearing loose and comfortable shoes and socks; if symptoms occur, apply local cold compresses or use topical drugs under the guidance of a doctor to relieve symptoms. If necessary, the dosage can be adjusted or administered intermittently.

5. Myelosuppression

Sunitinib may cause a decrease in white blood cells, platelets, or red blood cells, leading to infection, bleeding, or anemia. Response measures include regular hematology monitoring; seeking medical attention promptly when fever, bleeding tendency, or obvious fatigue occurs; paying attention to personal hygiene to prevent infection; and adjusting dosage or suspending medication under the guidance of a doctor. Hematopoietic support treatment can be supplemented when necessary.

6. Skin reaction

Rashes, itching, or dry skin are also more common. Response measures include keeping the skin clean and using non-irritating cleansing products; applying moisturizing cream or anti-itch ointment topically; avoiding scratching and exposure to the sun; if a severe rash or accompanying blisters occurs, seek medical attention immediately to check for serious skin reactions.

7. Heart-related side effects

A small number of patients may suffer from reduced cardiac function, arrhythmia or myocardial damage. Response measures include cardiac evaluation before treatment, especially for patients with previous heart disease; regular review of electrocardiogram and heart function; timely medical treatment when symptoms such as chest tightness, shortness of breath, and heart palpitations occur; and under the guidance of a doctor, the medication regimen can be adjusted to reduce cardiac risks.

In order to effectively manage the side effects of sunitinib, patients should maintain good communication, follow up with doctors regularly and report adverse reactions in a timely manner; develop healthy living habits, including a reasonable diet, regular work and rest, and moderate exercise; and perform dosage adjustments or symptomatic treatment under the guidance of a doctor. Through scientific side effect management, patients can not only complete the treatment course more safely, but also improve their quality of life and maximize drug efficacy.

Reference materials:https://www.drugs.com/